RECURSION PHARMACEUTICALS, INC. (RXRX)

SEC filing

RECURSION PHARMACEUTICALS, INC.

RXRX · CIK 1601830

4 · Feb 6, 2026 · Gibson Christopher sold 40K shares at $4.12/share ($164.8K); converted 40K shares; was granted 30.35K shares; reported 10.36K shares

Gibson Christopher sold 40K shares at $4.12/share ($164.8K); converted 40K shares; was granted 30.35K shares; reported 10.36K shares

Filed: Feb 6, 2026
Period: Feb 4, 2026
Accession: 0001601830-26-000008
Filer: RECURSION PHARMACEUTICALS, INC.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X05/wk-form4_1770418417.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1770418417.xml
Open SEC.gov